For healthcare professionals, life science professionals, and decision makers

About Us Contact Us

© 2025 - 2026

The Life Science Feed. All rights reserved.

A digital publication from Grá & Mawi Media Co.

Cardiology
Critical Care
Dentistry
Dermatology
Endocrinology
Gastroenterology
General Practice
Genetics
Geriatrics
Haematology

View all therapy areas →

•

Acne Vulgaris
Acute Kidney Injury
Acute Respiratory Distress Syndrome
ADHD
Adrenal Gland Diseases
Alzheimer Disease
Amyotrophic Lateral Sclerosis
Anxiety Disorders
Aortic Valve Stenosis
Aplastic Anemia

View all disease areas →

•

Case
Guidelines
Innovation
Insights
News
Policy
Practice
Research

Disease Area

renal cell carcinoma

Loading articles...

Evidence-based clinical insights for healthcare professionals.

About Us

About
Advertise With Us
AI Disclaimer
Contact Us
Editorial Policy

Legal

Accessibility
Cookie Policy
Copyright
Privacy Policy
Terms & Conditions

Therapy Areas

Cardiology
Dermatology
Endocrinology
Gastroenterology
Neurology
Oncology
Psychiatry
Pulmonology
Rare Diseases
Rheumatology

View all therapy areas →

© 2025–2026 The Life Science Feed. All rights reserved. A digital publication from Grá & Mawi Media Co.

?

?

0:00 / 0:00

CategoryKeyword

Renal Cell Carcinoma
Belzutifan Plus Pembrolizumab Approved for Adjuvant RCC
The FDA has approved belzutifan plus pembrolizumab for adjuvant renal cell carcinoma, offering a new option for patients at high risk of recurrence.
6 min readRead more